Correction to: Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes
Sarah Metzger(University Children's Hospital Zurich), Ana Guerreiro Stücklin(University Children's Hospital Zurich), Michael A. Grotzer(Boston Children's Hospital), Nicolas U. Gerber(University Children's Hospital Zurich), Annette Weiser(University Children's Hospital Zurich), Maria Otth(University of Bern), Niklaus Krayenbühl, Katrin Scheinemann(University of Lucerne)
Cited by 1
Related Papers
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|659
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
|Cancer Cell|2020|470
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
|Nature Communications|2019|372
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345